Virus watch: could tracking EBV save transplant patients from deadly complications?
NCT ID NCT04189835
First seen Nov 20, 2025 · Last updated Apr 30, 2026 · Updated 22 times
Summary
This study followed 509 kidney transplant recipients to see if regularly checking Epstein-Barr virus (EBV) levels in the blood could help predict serious infections, a type of cancer called PTLD, and death. The goal was to find out if persistent EBV in the blood is a warning sign that a patient's immune system is too suppressed. The results could help doctors personalize immunosuppressive treatment to reduce risks.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Aarhus University Hospital
Aarhus, Central Region Denmark, Denmark
-
Odense University Hospital
Odense, Region Syddanmark, Denmark
-
Rikshospitalet, Oslo Universitetssykehus
Oslo, Norway
Conditions
Explore the condition pages connected to this study.